Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:10 AM
Ignite Modification Date:
2025-12-25 @ 2:10 AM
NCT ID:
NCT00635960
Eligibility Criteria:
Inclusion Criteria:
* Definite/probable ALS according to El Escorial criteria
* Aged \> 40, \< 85 years
* Progression from onset
* Disease duration ≤3 years
* Treatment with Riluzole
Exclusion Criteria:
* Rapid disease progression in the first 6 months after diagnosis
* Patients with tracheostomy and/or Gastrostomy
* Disease duration \> 3 years
* Patient with exclusive bulbar or 2° motorneuron involvement
* Hepatic/renal failure
* Pregnant or breastfeeding
* Signs of active neoplasia
* Complicated Diabetes
* Severe hypertension
* Unable to undergo MRI exams
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
40 Years
Maximum Age:
85 Years
Study:
NCT00635960
Study Brief:
Protocol Section:
NCT00635960